Current Issue
Alert me when new journal issues are available via or via
Editorial board page ii Full-Text PDF (27 KB)
EJC NEWS, ISSUE 17, 2009 pages 2923-2927 Full-Text PDF (198 KB)
Editorial comment
Management of aggressive fibromatosis: Can we unravel the maze of treatment options?, 05 October 2009 Stefan Sleijfer pages 2928-2929 Full Text | Full-Text PDF (84 KB)
Short communication
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis, 22 September 2009 Anastasia Constantinidou, Robin L. Jones, Michelle Scurr, Omar Al-Muderis, Ian Judson pages 2930-2934 Abstract | Full Text | Full-Text PDF (103 KB)
Current perspective
Human papilloma virus in head and neck cancer: The need for a standardised assay to assess the full clinical importance, 22 September 2009 Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff, Chris J.L.M. Meijer, Peter J.F. Snijders, C. René Leemans pages 2935-2939 Abstract | Full Text | Full-Text PDF (118 KB)
Reviews
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer, 17 August 2009 Xavier B. Pivot, Rubi K. Li, Eva S. Thomas, Hyun-Cheol Chung, Luis E. Fein, Valorie F. Chan, Jacek Jassem, Fernando Hurtado de Mendoza, Pralay Mukhopadyay, Henri H. Roché pages 2940-2946 Abstract | Full Text | Full-Text PDF (137 KB)
Stereotactic body radiation therapy for liver metastases, 23 September 2009 Omar Dawood, Anand Mahadevan, Karyn A. Goodman pages 2947-2959 Abstract | Full Text | Full-Text PDF (175 KB)
Are we there yet? The state of the evidence base for guidelines on breaking bad news to cancer patients, 17 September 2009 C.L. Paul, T. Clinton-McHarg, R.W. Sanson-Fisher, H. Douglas, G. Webb pages 2960-2966 Abstract | Full Text | Full-Text PDF (157 KB)
Clinical oncology
QUOTEchemo: A patient-centred instrument to measure quality of communication preceding chemotherapy treatment through the patient’s eyes, 17 July 2009 Julia C.M. van Weert, Jesse Jansen, Gert-Jan de Bruijn, Janneke Noordman, Sandra van Dulmen, Jozien M. Bensing pages 2967-2976 Abstract | Full Text | Full-Text PDF (164 KB)
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer, 12 October 2009 J. Dauplat, G. Chene, C. Pomel, M.M. Dauplat, G.Le Bouëdec, F. Mishellany, N. Lagarde, Y.J. Bignon, P. Jaffeux, B. Aublet-Cuvelier, P. Dechelotte, J.L. Pouly, F. Penault-Llorca pages 2977-2983 Abstract | Full Text | Full-Text PDF (345 KB)
What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?, 31 July 2009 Matti Aapro, Agustí Barnadas, Robert C. Leonard, Maurizio Marangolo, Michael Untch, Lidia Ukarma, Hans-Ulrich Burger, Armin Scherhag, Bruno Osterwalder pages 2984-2991 Abstract | Full Text | Full-Text PDF (1140 KB)
Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy, 17 August 2009 Ralf Gertler, Robert Rosenberg, Tibor Schuster, Helmut Friess pages 2992-2999 Abstract | Full Text | Full-Text PDF (350 KB)
The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer, 10 September 2009 Wenli Lu, Michael Schaapveld, Liesbeth Jansen, Emad Bagherzadegan, Marko Mirza Sahinovic, Peter C. Baas, Leo M.H.C. Hanssen, Hans C.J. van der Mijle, Jan D. Brandenburg, Theo Wiggers, Geertruida H. De Bock pages 3000-3007 Abstract | Full Text | Full-Text PDF (311 KB)
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis, 22 September 2009 Verena Varadi, Annika Brendle, Andreas Brandt, Robert Johansson, Kerstin Enquist, Roger Henriksson, Ulrika Svenson, Björn Tavelin, Göran Roos, Kari Hemminki, Per Lenner, Asta Försti pages 3008-3016 Abstract | Full Text | Full-Text PDF (395 KB) | Add-Ons
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer, 18 September 2009 R.N. Whistance, T. Conroy, W. Chie, A. Costantini, O. Sezer, M. Koller, C.D. Johnson, S.A. Pilkington, J. Arraras, E. Ben-Josef, A.M. Pullyblank, P. Fayers, J.M. Blazeby, on behalf of the European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Group pages 3017-3026 Abstract | Full Text | Full-Text PDF (227 KB)
Paediatric oncology
Cardiac or cardiopulmonary transplantation in childhood cancer survivors: An increasing need?, 10 September 2009 Gill Levitt, Antoinette Anazodo, Michael Burch, Kathryn Bunch pages 3027-3034 Abstract | Full Text | Full-Text PDF (235 KB)
Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma, 28 September 2009 Gianni Bisogno, Andrea Ferrari, Arcangelo Prete, Chiara Messina, Eleonora Basso, Giovanni Cecchetto, Paolo Indolfi, Giovanni Scarzello, Paolo D’Angelo, Luigi De Sio, Andrea Di Cataldo, Modesto Carli pages 3035-3041 Abstract | Full Text | Full-Text PDF (241 KB)
Epidemiology and cancer prevention
Long-term meat intake and risk of breast cancer by oestrogen and progesterone receptor status in a cohort of Swedish women, 22 May 2009 Susanna C. Larsson, Leif Bergkvist, Alicja Wolk pages 3042-3046 Abstract | Full Text | Full-Text PDF (118 KB)
Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case–control study in Europe, 01 June 2009 Adrian Cassidy, Jessica Balsan, Aurélien Vesin, Xifeng Wu, Triantafillos Liloglou, Christian Brambilla, Jean-François Timsit, John K. Field, EUELC Consortium pages 3047-3053 Abstract | Full Text | Full-Text PDF (131 KB)
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant, 22 June 2009 Saverio Caini, Sara Gandini, Francesco Sera, Sara Raimondi, Maria Concetta Fargnoli, Mathieu Boniol, Bruce K. Armstrong pages 3054-3063 Abstract | Full Text | Full-Text PDF (165 KB) | Add-Ons
The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients, 03 June 2009 Chantal C. Orgéas, Per Hall, Sara Wedrén, Paul W. Dickman, Kamila Czene pages 3064-3073 Abstract | Full Text | Full-Text PDF (167 KB)
Experimental oncology
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma, 07 September 2009 Joost J.C. Verhoeff, Lukas J.A. Stalpers, An Claes, Koos E. Hovinga, Gijsbert D. Musters, W. Peter Vandertop, Dick J. Richel, William P.J. Leenders, Wouter R. van Furth pages 3074-3080 Abstract | Full Text | Full-Text PDF (408 KB)
Analysis of Ki-67 and Bcl-2 protein expression in normal colorectal mucosa of women with breast cancer, 28 September 2009 Edílson C. Sousa-Júnior, Airlane P. Alencar, Benedito B. da Silva pages 3081-3086 Abstract | Full Text | Full-Text PDF (271 KB)
Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications, 09 October 2009 Steven G. Gray, Nael Al-Sarraf, Anne-Marie Baird, Mary-Clare Cathcart, Eilish McGovern, Kenneth J. O’Byrne pages 3087-3097 Abstract | Full Text | Full-Text PDF (772 KB)
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size, 07 October 2009 Guozheng Liu, Shuping Dou, Minmin Liang, Xiangji Chen, Mary Rusckowski, Donald J. Hnatowich pages 3098-3103 Abstract | Full Text | Full-Text PDF (482 KB)
MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines, 09 October 2009 M.K. Muniyappa, P. Dowling, M. Henry, P. Meleady, P. Doolan, P. Gammell, M. Clynes, N. Barron pages 3104-3118 Abstract | Full Text | Full-Text PDF (1962 KB)
Calendar page I Full-Text PDF (18 KB)
Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
